Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines

Lici A. Schurig-Briccio, Takahiro Yano, Harvey Rubin, Robert B. Gennis

Research output: Contribution to journalArticle

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is currently one of the principal multiple drug resistant bacterial pathogens causing serious infections, many of which are life-threatening. Consequently, new therapeutic targets are required to combat such infections. In the current work, we explore the type 2 Nicotinamide adenine dinucleotide reduced form (NADH) dehydrogenases (NDH-2s) as possible drug targets and look at the effects of phenothiazines, known to inhibit NDH-2 from Mycobacterium tuberculosis. NDH-2s are monotopic membrane proteins that catalyze the transfer of electrons from NADH via flavin adenine dinucleotide (FAD) to the quinone pool. They are required for maintaining the NADH/Nicotinamide adenine dinucleotide (NAD+) redox balance and contribute indirectly to the generation of proton motive force. NDH-2s are not present in mammals, but are the only form of respiratory NADH dehydrogenase in several pathogens, including S. aureus. In this work, the two putative ndh genes present in the S. aureus genome were identified, cloned and expressed, and the proteins were purified and characterized. Phenothiazines were shown to inhibit both of the S. aureus NDH-2s with half maximal inhibitory concentration (IC50) values as low as 8 μM. However, evaluating the effects of phenothiazines on whole cells of S. aureus was complicated by the fact that they are also acting as uncouplers of oxidative phosphorylation. This article is part of a Special Issue entitled: 18th European Bioenergetic Conference.

Original languageEnglish (US)
Pages (from-to)954-963
Number of pages10
JournalBiochimica et Biophysica Acta - Bioenergetics
Volume1837
Issue number7
DOIs
StatePublished - Jul 2014

Fingerprint

Phenothiazines
Vitamin K 2
NAD
Staphylococcus aureus
Oxidoreductases
NADH Dehydrogenase
Pathogens
Genes
Flavin-Adenine Dinucleotide
Methicillin
Proton-Motive Force
Mammals
Oxidative Phosphorylation
Methicillin-Resistant Staphylococcus aureus
Infection
Mycobacterium tuberculosis
Pharmaceutical Preparations
Energy Metabolism
Inhibitory Concentration 50
Oxidation-Reduction

Keywords

  • Bioenergetics/electron transfer complex
  • Enzyme inhibitor
  • NADH dehydrogenase
  • Phenothiazine
  • Respiratory chain
  • Staphylococcus aureus

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Cell Biology

Cite this

Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines. / Schurig-Briccio, Lici A.; Yano, Takahiro; Rubin, Harvey; Gennis, Robert B.

In: Biochimica et Biophysica Acta - Bioenergetics, Vol. 1837, No. 7, 07.2014, p. 954-963.

Research output: Contribution to journalArticle

@article{f084bd2ba7794ef7a2f1bd3bf01cd167,
title = "Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines",
abstract = "Methicillin-resistant Staphylococcus aureus (MRSA) is currently one of the principal multiple drug resistant bacterial pathogens causing serious infections, many of which are life-threatening. Consequently, new therapeutic targets are required to combat such infections. In the current work, we explore the type 2 Nicotinamide adenine dinucleotide reduced form (NADH) dehydrogenases (NDH-2s) as possible drug targets and look at the effects of phenothiazines, known to inhibit NDH-2 from Mycobacterium tuberculosis. NDH-2s are monotopic membrane proteins that catalyze the transfer of electrons from NADH via flavin adenine dinucleotide (FAD) to the quinone pool. They are required for maintaining the NADH/Nicotinamide adenine dinucleotide (NAD+) redox balance and contribute indirectly to the generation of proton motive force. NDH-2s are not present in mammals, but are the only form of respiratory NADH dehydrogenase in several pathogens, including S. aureus. In this work, the two putative ndh genes present in the S. aureus genome were identified, cloned and expressed, and the proteins were purified and characterized. Phenothiazines were shown to inhibit both of the S. aureus NDH-2s with half maximal inhibitory concentration (IC50) values as low as 8 μM. However, evaluating the effects of phenothiazines on whole cells of S. aureus was complicated by the fact that they are also acting as uncouplers of oxidative phosphorylation. This article is part of a Special Issue entitled: 18th European Bioenergetic Conference.",
keywords = "Bioenergetics/electron transfer complex, Enzyme inhibitor, NADH dehydrogenase, Phenothiazine, Respiratory chain, Staphylococcus aureus",
author = "Schurig-Briccio, {Lici A.} and Takahiro Yano and Harvey Rubin and Gennis, {Robert B.}",
year = "2014",
month = "7",
doi = "10.1016/j.bbabio.2014.03.017",
language = "English (US)",
volume = "1837",
pages = "954--963",
journal = "Biochimica et Biophysica Acta - Bioenergetics",
issn = "0005-2728",
publisher = "Elsevier",
number = "7",

}

TY - JOUR

T1 - Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines

AU - Schurig-Briccio, Lici A.

AU - Yano, Takahiro

AU - Rubin, Harvey

AU - Gennis, Robert B.

PY - 2014/7

Y1 - 2014/7

N2 - Methicillin-resistant Staphylococcus aureus (MRSA) is currently one of the principal multiple drug resistant bacterial pathogens causing serious infections, many of which are life-threatening. Consequently, new therapeutic targets are required to combat such infections. In the current work, we explore the type 2 Nicotinamide adenine dinucleotide reduced form (NADH) dehydrogenases (NDH-2s) as possible drug targets and look at the effects of phenothiazines, known to inhibit NDH-2 from Mycobacterium tuberculosis. NDH-2s are monotopic membrane proteins that catalyze the transfer of electrons from NADH via flavin adenine dinucleotide (FAD) to the quinone pool. They are required for maintaining the NADH/Nicotinamide adenine dinucleotide (NAD+) redox balance and contribute indirectly to the generation of proton motive force. NDH-2s are not present in mammals, but are the only form of respiratory NADH dehydrogenase in several pathogens, including S. aureus. In this work, the two putative ndh genes present in the S. aureus genome were identified, cloned and expressed, and the proteins were purified and characterized. Phenothiazines were shown to inhibit both of the S. aureus NDH-2s with half maximal inhibitory concentration (IC50) values as low as 8 μM. However, evaluating the effects of phenothiazines on whole cells of S. aureus was complicated by the fact that they are also acting as uncouplers of oxidative phosphorylation. This article is part of a Special Issue entitled: 18th European Bioenergetic Conference.

AB - Methicillin-resistant Staphylococcus aureus (MRSA) is currently one of the principal multiple drug resistant bacterial pathogens causing serious infections, many of which are life-threatening. Consequently, new therapeutic targets are required to combat such infections. In the current work, we explore the type 2 Nicotinamide adenine dinucleotide reduced form (NADH) dehydrogenases (NDH-2s) as possible drug targets and look at the effects of phenothiazines, known to inhibit NDH-2 from Mycobacterium tuberculosis. NDH-2s are monotopic membrane proteins that catalyze the transfer of electrons from NADH via flavin adenine dinucleotide (FAD) to the quinone pool. They are required for maintaining the NADH/Nicotinamide adenine dinucleotide (NAD+) redox balance and contribute indirectly to the generation of proton motive force. NDH-2s are not present in mammals, but are the only form of respiratory NADH dehydrogenase in several pathogens, including S. aureus. In this work, the two putative ndh genes present in the S. aureus genome were identified, cloned and expressed, and the proteins were purified and characterized. Phenothiazines were shown to inhibit both of the S. aureus NDH-2s with half maximal inhibitory concentration (IC50) values as low as 8 μM. However, evaluating the effects of phenothiazines on whole cells of S. aureus was complicated by the fact that they are also acting as uncouplers of oxidative phosphorylation. This article is part of a Special Issue entitled: 18th European Bioenergetic Conference.

KW - Bioenergetics/electron transfer complex

KW - Enzyme inhibitor

KW - NADH dehydrogenase

KW - Phenothiazine

KW - Respiratory chain

KW - Staphylococcus aureus

UR - http://www.scopus.com/inward/record.url?scp=84901820211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901820211&partnerID=8YFLogxK

U2 - 10.1016/j.bbabio.2014.03.017

DO - 10.1016/j.bbabio.2014.03.017

M3 - Article

C2 - 24709059

AN - SCOPUS:84901820211

VL - 1837

SP - 954

EP - 963

JO - Biochimica et Biophysica Acta - Bioenergetics

JF - Biochimica et Biophysica Acta - Bioenergetics

SN - 0005-2728

IS - 7

ER -